Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Earnings Per Share (Tables)

v3.21.2
Note 9 - Earnings Per Share (Tables)
3 Months Ended
Sep. 30, 2021
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Quarter Ended

September 30,

 
   

2021

   

2020

 

Earnings per share – basic:

               
Net earnings, including noncontrolling interest   $ 68,981     $ 33,395  
Less net earnings (loss) attributable to noncontrolling interest     (634

)

    -

 

Net earnings attributable to Bio-Techne   $ 69,615     $ 33,395  
Income allocated to participating securities     (36 )     (21)  
Income available to common shareholders   $ 69,579     $ 33,374  
                 

Weighted-average shares outstanding - basic

    39,094       38,536  

Earnings per share - basic

  $ 1.78     $ 0.87  
                 

Earnings per share – diluted:

               
Net earnings, including noncontrolling interest   $ 68,981     $ 33,395  
Less net earnings (loss) attributable to noncontrolling interest     (634 )     -  

Net earnings attributable to Bio-Techne

  $ 69,615     $ 33,395  
Income allocated to participating securities     (36

)

    (21

)

Income available to common shareholders   $ 69,579     $ 33,374  
                 

Weighted average shares outstanding - basic

    39,094       38,536  

Dilutive effect of stock options and restricted stock units

    2,064       1,489  

Weighted average common shares outstanding - diluted

    41,158       40,025  

Earnings per share - diluted

  $ 1.69     $ 0.83